Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus regimens in elderly kidney transplant
NCT00254709Phase 4Completed
- Sponsor
- Pfizer
- Start
- Oct 2002
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of sirolimus in kidney transplant rejection (2 arms), sponsored by Pfizer. Primary endpoint: Renal function measured by Cockroft-Gault formula or serum creatinine at 12 months. Started Oct 2002; status: completed.
02
Drugs
sirolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00254709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254709.